European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision makingNicolaus Andratschke, Carsten Nieder, Jonas Willmann et al.|The Lancet Oncology|2022Cited by 192
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?Joline S.W. Lind, Egbert F. Smit, Martijn R. Meijerink et al.|European Radiology|2010Cited by 84
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-upAlona Zer, Natasha B. Leighl, Oliver Gautschi et al.|Annals of Oncology|2025Cited by 74
Re-irradiation in clinical practice: Results of an international patterns of care survey within the framework of the ESTRO-EORTC E2-RADIatE platformJonas Willmann, Nicolaus Andratschke, Ane Appelt et al.|Radiotherapy and Oncology|2023Cited by 72
Outcome after PORT in ypN2 or R1/R2 versus no PORT in ypN0 Stage III-N2 NSCLC after Induction Chemotherapy and ResectionCharlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters et al.|Journal of Thoracic Oncology|2016Cited by 25